Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes

Leukemia Research

Volumn 30, Issue 3, 2006, Pages 247-253

  Lundberg, Lars Göran ^a   Hellström Lindberg, Eva ^b   Kanter Lewensohn, Lena ^b   Lerner, Richard ^b   Palmblad, Jan ^b,c  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Angiogenesis; Apoptosis; CD34; Endothelium; International Prognostic Scoring System; Myelodysplastic syndrome

Indexed keywords

CD34 ANTIGEN; KI 67 ANTIGEN; LACTATE DEHYDROGENASE;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; BLAST CELL; BLOOD CELL COUNT; BONE MARROW EXAMINATION; CELL PROLIFERATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOGENETICS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MYELODYSPLASTIC SYNDROME; NICK END LABELING; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA WITH EXCESS BLASTS; SCORING SYSTEM; SURVIVAL; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; APOPTOSIS; BLAST CRISIS; BLOOD CELL COUNT; BONE MARROW; CELL PROLIFERATION; COHORT STUDIES; DISEASE-FREE SURVIVAL; ERYTHROCYTE INDICES; FEMALE; HUMANS; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS;

EID: 30144436715     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.07.003     Document Type: Article

References (31)

1. J.M. Bennett, D. Catovsky, M.T. Daniel, G. Flandrin, D.A. Galton, H.R. Gralnick The French-American-British (FAB) group Proposals for the classification of the myelodysplastic syndromes Br J Haematol 51 1982 189 199
2. WHO classification tumours of haematopoietic and lymphoid tissues 2001 IARC Press Lyon
3. P. Greenberg, C. Cox, M.M. LeBeau, P. Fenaux, P. Morel, and G. Sanz International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 1997 2079 2088
4. A. Riccardi, M. Giordano, P. Giordano, E. Cassano, M. Girino, and M. Cazzola Prognostic parameters in myelodysplastic syndromes: a multiple regression analysis Eur J Haematol 40 1988 158 162
5. A. Rios, M.C. Canizo, M.A. Sanz, T. Vallespi, G. Sanz, and M. Torrabadella Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors Br J Haematol 75 1990 26 33
6. C. Aul, N. Gattermann, A. Heyll, U. Germing, G. Derigs, and W. Schneider Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system Leukemia 6 1992 52 59
7. P. Morel, C. Declerq, M. Hebbar, F. Bauters, and P. Fenaux Prognostic factors in myelodysplastic syndromes: critical analysis of the impact of age and gender and failure to identify a very low risk group using standard mortality ratio techniques Br J Haematol 94 1996 116 119
8. G.F. Sanz, M.A. Sanz, T. Vallespi, M.C. Canizo, M. Torrabadella, and S. Garcia Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients Blood 74 1989 395 408
9. R. Hast, E. Hellstrom-Lindberg, L. Ohm, M. Bjorkholm, F. Celsing, and I.M. Dahl No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease Leukemia 17 2003 1827 1833
10. N.B. Westwood, and G.J. Mufti Apoptosis in the myelodysplastic syndromes Curr Hematol Rep 2 2003 186 192
11. E. Hellstrom-Lindberg, C. Willman, A.J. Barrett, and Y. Saunthararajah Achievements in understanding and treatment of myelodysplastic syndromes Hematology (Am Soc Hematol Educ Prog) 2000 110 132
12. R. Tehranchi, B. Fadeel, A.M. Forsblom, B. Christensson, J. Samuelsson, and B. Zhivotovsky Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors Blood 101 2003 1080 1086
13. A. Raza, S. Gezer, S. Mundle, X.Z. Gao, S. Alvi, and R. Borok Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes Blood 86 1995 268 276
14. E. Hellstrom-Lindberg, L. Kanter-Lewensohn, and A. Ost Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin Leuk Res 21 1997 415 425
15. G. Pruneri, F. Bertollini, D. Soligo, N. Carboni, A. Cortelezzi, and P.F. Ferrucci Angiogenesis in myelodysplastic syndromes Br J Cancer 81 1999 1398 1401
16. A. Aguayo, H. Kantarijian, T. Manshouri, C. Gidel, E. Estey, and D. Thomas Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes Blood 96 2000 2240 2245
17. P. Korkolopoulou, E. Apostolidou, P.M. Pavlopoulos, N. Kavantzas, N. Vyniou, and I. Thymara Prognostic evaluation of microvascular network in myelodysplastic syndromes Leukemia 15 2001 1369 1376
18. D. Ribatti, G. Polimeno, A. Vacca, A. Marzullo, E. Crivellato, and B. Nico Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes Leukemia 16 2002 1680 1684
19. E. Zetterberg, L.G. Lundberg, and J. Palmblad Identification of blood vessels in the bone marrow from patients with chronic myelogenous leukemia and polycytemia Scand J Lab Clin Med 64 2004 641 648
20. D. Campioni, M. Punturieri, A. Bardi, S. Moretti, E. Tammiso, and F. Lanza "In vitro" evaluation of bone marrow angiogenesis in myelodysplastic syndromes: a morphological and functional approach Leuk Res 28 2004 9 17
21. A. Aguayo, H.M. Kantarjian, E.H. Estey, F.J. Giles, S. Verstovsek, and T. Manshouri Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes Cancer 95 2002 1923 1930
22. B. Brunner, E. Gunsilius, P. Schumacher, H. Zwierzina, G. Gastl, and R. Stauder Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia J Hematother Stem Cell Res 11 2002 119 125
23. L. Kanter-Lewensohn, E. Hellström-Lindberg, Y. Kock, A. Elmhorn-Rosenborg, and Å. Öst Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry Eur J Haematol 56 1996 124 129
24. E. Hellstrom-Lindberg, L. Kanter-Lewensohn, J. Nichol, and A. Ost Spontaneous and cytokine-induced thrombocytopenia in myelodysplastic syndromes: serum thrombopoietin levels and bone marrow morphology. Scandinavian MDS Group, Sweden and Norway Br J Haematol 105 1999 966 973
25. L.G. Lundberg, R. Lerner, P. Sundelin, R. Rogers, J. Folkman, and J. Palmblad Bone marrow in polycythemia vera, chronic myelocytic leukemia and myelofibrosis has an increased vascularity Am J Pathol 157 2000 15 19
26. E. Bråkenhielm, R. Cao, B. Gao, B. Angelin, B. Cannon, and P. Parini Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice Circ Res 94 2004 1579 1588
27. E. Hellstrom-Lindberg, K.H. Robert, G. Gahrton, G. Lindberg, A.M. Forsblom, and Y. Kock A predictive model for the clinical response to low dose ara-C: a study of 102 patients with myelodysplastic syndromes or acute leukaemia Br J Haematol 81 1992 503 511
28. M.H. Mangi, and A.C. Newland Angiogenesis and angiogenic mediators in haematological malignancies Br J Haematol 111 2000 43 51
29. S.Y. Yoon, A. Teferri, and C.H. Li Bone marrow stromal cell distribution of basic fibroblast growth factor in chronic myeloid disorders Haematologica 86 2001 52 57
30. Q. Hu, A.L. Dey, Y. Yang, Y. Shen, I.B. Jilani, and E.H. Estey Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes Cancer 100 2004 1884 1891
31. S. Verstovsek, E. Estey, T. Manshouri, M. Keating, H. Kantarjian, and F.J. Giles High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndrome Leuk Lymphoma 42 2001 511 516